biotech

Segui

A billionaire-backed biotech startup, R3 Bio, is developing genetically engineered 'organ sacks'—whole organ systems without a brain—as an alternative to animal testing. This idea comes as the Trump administration phases out animal experimentation across the federal government. A cofounder states the long-term goal is to create human versions.

Riportato dall'IA

Science Corporation, a brain-computer interface startup founded by former Neuralink president Max Hodak, has announced a new division focused on extending the viability of human organs for transplantation. The company unveiled a prototype machine designed to preserve organs for longer periods. This initiative expands beyond their core work in neural technology.

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta